GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auro Laboratories Ltd (BOM:530233) » Definitions » Selling and Marketing Expense

Auro Laboratories (BOM:530233) Selling and Marketing Expense : ₹0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Auro Laboratories Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Auro Laboratories's Selling and Marketing Expense for the three months ended in Dec. 2024 was ₹0.0 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.0 Mil.

Auro Laboratories Selling and Marketing Expense Historical Data

The historical data trend for Auro Laboratories's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Auro Laboratories Selling and Marketing Expense Chart

Auro Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.94 10.02 6.38 8.02 5.99

Auro Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Auro Laboratories Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Auro Laboratories Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Auro Laboratories's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Auro Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auro Laboratories Ltd (BOM:530233) » Definitions » Selling and Marketing Expense
Comparable Companies
BOM:524518 BOM:540686 BOM:532384 BOM:524824 BOM:524412 NSE:VAISHALI NSE:MADHAVBAUG BOM:524828 BOM:532989 BOM:537536 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
S.K. Ahire Marg, 314, 3rd Floor, T.V. Industrial Estate, Worli, Mumbai, MH, IND, 400 030
Website
http://www.aurolabs.com
Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.

Auro Laboratories Headlines

No Headlines